Nationally Recognized Addiction Expert Kelly J. Clark, MD,

New Post Public Reply Private Reply Replies (1) Message Board
Kgem
248
Nationally Recognized Addiction Expert Kelly J. Clark, MD, MBA, Joins Advisory Board of DisposeRx, Inc.

7:25 am ET March 5, 2019 (PR Newswire)

DisposeRx Inc. (http://www.disposerx.com) today announced that nationally recognized physician, addiction expert and business executive, Kelly J. Clark, MD, MBA, will serve as a strategic advisor for the company as it continues to expand its relationships with health plans, payors, pharmacy benefit managers, associations and pharmacies nationwide. DisposeRx's mission is to eradicate the misuse of unused medication and is accomplished through educational efforts and DisposeRx's innovative site-of-use technology. By bringing attention to the dangers of unintended medication poisonings and the environmental risks of unused medications, DisposeRx is able to provide communities with an at-home medication approach that is proactive, simple to use, clean and eco-friendly. DisposeRx packets are provided to customers filling opioid prescriptions at many national pharmacy locations such as Walmart, Rite Aid, Kroger, Harris Teeter as well as many independent and community pharmacies. DisposeRx packets are distributed to many hospitals and independent community groups through America's largest wholesalers, AmerisourceBergen, Cardinal Health and McKesson, and are used by law enforcement, hospices and healthcare systems across the country.

https://mma.prnewswire.com/media/749673/DisposeRx_Logo.jpg

Dr. Kelly Clark is the Founder of Addiction Crisis Solutions, a company focused on preventing addiction and transforming addiction care into evidence-based and cost-effective practice. She serves as President of the American Society of Addiction Medicine, over 6000 physicians representing the largest medical professional organization focusing on addictive disease, as well as Steering Committee Member of the National Academy of Medicine's Action Collaborative to Combat the US Opioid Crisis.

Dr. Clark's previous roles have included Chief Medical Officer of Behavioral Health Group and CleanSlate Centers; Medical Director for CVS Caremark and CDPHP; and providing expertise to the FDA, SAMHSA, DOJ, and the US Comptroller General. She is currently active on the Association of Managed Care Pharmacy's Addiction Advisory Group and as a founding member of the Advisory Board of the National Rx Drug Abuse and Heroin Summit.

"The medicine cabinets in our country are stocked with too many unused controlled substances each presenting a risk of misuse and unintentional poisoning," stated Dr. Kelly Clark. "I am thrilled to assist the team at DisposeRx in expanding options for consumers to rid their homes of these potentially deadly pharmaceuticals in ways that are convenient, immediate, and protective of our water supplies."

Dr. John W. Holaday, Chief Executive Officer of DisposeRx stated, "We are very pleased to have Dr. Kelly Clark as a strategic advisor as we continue to expanded opportunities for our unique and patent-pending technology." Dr. Holaday continued, "Our programs, business, and outreach efforts will be vastly informed by Kelly's extensive experience, education and accomplishments. With her appointment to our team, our goal of ridding American homes of the ticking time bombs of dangerous unused medications has moved closer to becoming a reality."

Dr. Clark earned an MBA from The Fuqua School of Business at Duke University, Durham, NC; her medical degree from University of Wisconsin, Madison, WI; and a bachelor degree in psychology from Coe College, Cedar Rapids, IA. She completed residency in psychiatry at the Medical College of Wisconsin and is currently board certified in both addiction medicine and psychiatry. With expertise in payment models, quality metrics, medical-behavioral health integration, and clinical care delivery systems, as well as a wealth of clinical experience treating people with addictive disease, Dr. Clark currently focuses on the epidemic of opioid addiction.

About DisposeRx PacketsDisposeRx packets contain a blend of patented and proprietary solidifying materials that provide a site-of-use solution for the disposal of unused or expired medications through drug neutralizing technology. When water and the DisposeRx powder are added to drugs in the prescription vial and shaken, the drugs are dissolved and then chemically and physically sequestered in a viscous polymer gel made from materials that are FDA approved for oral medications.

For more information and to order DisposeRx packets please visit our website at https://disposerx.com/

About DisposeRx, Inc.DisposeRx, Inc. is a drug disposal company that provides a solution to eradicate the misuse of unused medications. With offices in North Carolina, the Company is spearheading programs to educate communities about at-home site-of-use medication disposal solutions, preventing drug addictions and poisonings, overdoses and deaths. DisposeRx both chemically and physically sequesters medications in a viscous gel, which eliminates the opportunity for misuse and unintentional human and environmental exposure. DisposeRx's simple-to-use disposal solution enables ultimate users to secure a healthier home by facilitating the easy disposal of unwanted neutralized medications.



Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 416

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 244

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 268

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 267

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 191

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 233

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 260

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Rights for Paragon 28, Inc. Shareholders: Essential Info

Updated Category News Views 85

Legal Rights for Shareholders of Paragon 28, Inc. Attention shareholders of Paragon 28, Inc. (NYSE: FNA): As developments unfold regarding potential legal action related to financial misconduct, it is crucial for you to understand your rights and options. If you purchased shares of FNA during the specified class period, there are steps you can take to ensure that your...

Continue Reading
Embecta Set for Upcoming Fiscal Quarter Conference Call

Updated Category News Views 305

Embecta Corp. Financial Results Conference Call Embecta Corp. (“embecta”) (Nasdaq: EMBC), a prominent global player in diabetes care, is gearing up to present its financial performance for the fiscal second quarter of 2025. This pivotal event will offer stakeholders a comprehensive look at the company's recent achievements and ongoing operational updates. Conference...

Continue Reading
Investors Alert: HealthEquity, Inc. under Investigation Now!

Updated Category News Views 153

Investigation of HealthEquity, Inc. Pomerantz LLP is currently investigating claims on behalf of investors from HealthEquity, Inc. (NASDAQ: HQY). Investors who believe they may have been impacted are encouraged to reach out for further information. This investigation focuses on whether HealthEquity and certain officers or directors have been involved in securities fraud...

Continue Reading
Enhancing Access to Mental Health and Dermatology Services

Updated Category News Views 259

Health-E Commerce Teams Up with Sesame for Better Care The new collaboration significantly shortens waiting periods for those seeking mental health and dermatology consultations, delivering substantial savings for millions enrolled in tax-advantaged FSAs and HSAs. Accessible Mental Health and Dermatology Solutions Health-E Commerce, the parent organization behind FSA...

Continue Reading
Massive Gains Expected for Hyperliquid Amid Altcoin Buzz

Updated Category News Views 281

Hyperliquid's Promising Future in the Crypto Market As the cryptocurrency landscape continues to evolve, analysts are closely observing the potential of various altcoins. Recently, a well-known crypto analyst, Sherpa, has highlighted the altcoin Hyperliquid, predicting an exciting journey ahead for its utility token, HYPE. Analyst’s Predictions for Hyperliquid Expected...

Continue Reading